Description
VISITECT CD4 Advanced Disease Rapid Test
The VISITECT CD4 Advanced Disease Rapid Test is a manually operated semi-quantitative assay designed to estimate CD4 protein levels on the surface of CD4+ T cells in human whole blood. It provides a quick indication of whether CD4 levels are above or below 200 cells/μL in prediagnosed HIV patients. This rapid test is crucial for managing advanced HIV disease and optimizing patient treatment plans.
Key Benefits
- Rapid Estimation: Determines CD4+ T cell count levels quickly.
- Fast Results: Provides accurate results within just 40 minutes.
- Flexible Testing: Can be used anywhere, anytime.
- Improved Patient Management: Helps reduce patient loss to follow-up.
Specifications
- Sample Type: Whole blood (capillary or EDTA venous)
- Capillary Sensitivity: 89.3%
- Capillary Specificity: 92.3%
- Venous Sensitivity: 86.3%
- Venous Specificity: 92.8%
- Assay Time: 40 minutes
- Storage: 2-30℃
- Shelf Life: 12 months
Ordering Information
| Product Description | Specimen | Catalog No. | Format | Cut-off Value | Kit Size | Qualification |
|---|---|---|---|---|---|---|
| VISITECT CD4 Advanced Disease | WB (fingerstick/EDTA) | AB376 | Cassette | ≈ 200 cells/μL | 25 Tests/Kit | CE marked, WHO PQ |
Please note: The VISITECT CD4 Advanced Disease Rapid Test is not available for sale in the United States. For EU and other countries, please contact us for further details.
